We are live on ! Find out more
PPC

Park Place Capital Portfolio holdings

AUM $499M
1-Year Est. Return 14.38%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+14.38%
3 Year Est. Return
+49.65%
5 Year Est. Return
10 Year Est. Return
AUM
$354M
AUM Growth
-$1.83M
Cap. Flow
-$14.7M
Cap. Flow %
-4.16%
Top 10 Hldgs %
29.19%
Holding
1,043
New
39
Increased
227
Reduced
328
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWW icon
976
Wolverine World Wide
WWW
$1.56B
$1.32K ﹤0.01%
90
EHC icon
977
Encompass Health
EHC
$12.4B
$1.29K ﹤0.01%
19
-250
-93% -$15.7K
FBIN icon
978
Fortune Brands Innovations
FBIN
$6.04B
$1.22K ﹤0.01%
17
-19
-53% -$1.21K
DAVA icon
979
Endava
DAVA
$154M
$1.14K ﹤0.01%
22
VTRS icon
980
Viatris
VTRS
$19.5B
$1.11K ﹤0.01%
111
NICE icon
981
Nice
NICE
$5.74B
$1.03K ﹤0.01%
5
IMCR icon
982
Immunocore
IMCR
$1.66B
$1.02K ﹤0.01%
+17
New +$970
NXST icon
983
Nexstar Media Group
NXST
$6.01B
$999 ﹤0.01%
6
EMKR
984
DELISTED
Emcore Corp
EMKR
$978 ﹤0.01%
130
+7
+6% +$63
SIRI icon
985
SiriusXM
SIRI
$10.1B
$929 ﹤0.01%
21
-55
-72% -$2.08K
ACIW icon
986
ACI Worldwide
ACIW
$5.6B
$904 ﹤0.01%
39
FROG icon
987
JFrog
FROG
$10.1B
$886 ﹤0.01%
32
KRTX
988
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$867 ﹤0.01%
4
XENE icon
989
Xenon Pharmaceuticals
XENE
$6.21B
$847 ﹤0.01%
+22
New +$875
SEDG icon
990
SolarEdge
SEDG
$1.99B
$807 ﹤0.01%
3
B
991
Barrick Mining
B
$69.2B
$796 ﹤0.01%
47
BCRX icon
992
BioCryst Pharmaceuticals
BCRX
$2.4B
$788 ﹤0.01%
112
NARI
993
DELISTED
Inari Medical, Inc. Common Stock
NARI
$756 ﹤0.01%
13
GH icon
994
Guardant Health
GH
$21.3B
$752 ﹤0.01%
21
OXY.WS icon
995
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
$746 ﹤0.01%
20
HTLD icon
996
Heartland Express
HTLD
$966M
$738 ﹤0.01%
45
CSTL icon
997
Castle Biosciences
CSTL
$912M
$727 ﹤0.01%
53
MRTX
998
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$723 ﹤0.01%
20
RVLV icon
999
Revolve Group
RVLV
$1.74B
$705 ﹤0.01%
43
SWTX
1000
DELISTED
SpringWorks Therapeutics
SWTX
$629 ﹤0.01%
24

Similar funds

Park Place Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Park Place Capital held 1,043 positions worth $354M, down 0.51% from $356M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Park Place Capital withdrew a net $14.7M in Q2 2023, closing 39 positions and reducing 328 holdings. Its most notable exit was Revvity, an estimated $157K position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Park Place Capital opened a new position in iShares Intermediate Government/Credit Bond ETF worth $1.03M.

  • Park Place Capital's largest Q2 2023 buy was iShares Intermediate Government/Credit Bond ETF: 10,000 shares worth $1.03M.
  • Park Place Capital added most to iShares Core S&P Mid-Cap ETF in Q2 2023, an estimated $801K increase.
  • Park Place Capital's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $4.49M.
  • Park Place Capital fully exited Revvity in Q2 2023, selling an estimated $157K.
  • Park Place Capital's ten largest holdings make up 29% of its $354M portfolio in Q2 2023.
  • Park Place Capital opened 39 new positions and closed 39 in Q2 2023.
  • Park Place Capital's portfolio value fell 0.51% quarter-over-quarter to $354M.

Based on Park Place Capital's 13F filing for Q2 2023, filed 4 Aug 2023.